How Monoclonal Antibodies Work Against COVID-19

Monoclonal antibodies have the remarkable ability to save your life by preventing severe COVID-19. But there’s a catch. You must talk with your doctor about getting this treatment after you’re diagnosed with COVID-19 and while your symptoms are in the mild-to-moderate stage.

Once your doctor prescribes monoclonal antibodies, the next step is talking with our team at Align Infusion in Metairie, Louisiana. We have the expertise to safely administer your COVID antibody infusion therapy while you relax in the comfort of their office.

Here’s what you should know about monoclonal antibody treatment for COVID-19.

Antibodies explained

Your immune system protects you from harmful invaders such as viruses, bacteria, and toxins. To do the job, it produces an antibody for each unique invader that enters your body.

Antibodies are specialized Y-shaped proteins that circulate in your bloodstream, searching for their target. Upon encountering the invader they’re designed to identify, antibodies immediately bind to the substance. This triggers your immune system to send out cells that destroy or neutralize the dangerous substance.

About monoclonal antibodies

Monoclonal antibodies are produced in the lab. They’re designed to work like the antibodies produced by your immune system, but each one is precisely engineered to target a specific type of cell. 

Since monoclonal antibodies are made to bind with different substances, they can treat an array of problems. The first monoclonal antibody ever approved targeted the body’s own immune cells, with the goal of stopping them from attacking a transplanted kidney. 

Today, monoclonal antibodies are available to treat everything from chronic inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and psoriasis, to lupus and several types of cancer. The newest monoclonal antibodies identify the COVID-19 virus. 

How COVID-19 monoclonal antibodies work

Have you seen the images of the SARS-CoV-2 virus that causes COVID-19? If you have, then you know that it’s covered in spike-like structures that stick up from the surface of the virus.

These spikes fuse to cells in your body and start a chemical reaction that allows the SARS-CoV-2 virus to enter the cell. And once it gets inside the cell, it starts making you sick.

Scientists discovered that the very structures that enable SARS-CoV-2 to invade cells — the spikes — are also the perfect target for monoclonal antibodies. From there, they went to work producing antibodies that would identify and bind with the spikes.

When monoclonal antibodies attach to the SARS-CoV-2 spikes, they stop the virus from getting inside the cell. As a result, they slow down COVID-19’s impact on your body, reducing the severity of your illness and helping to keep you out of the hospital.

Candidates for COVID-19 monoclonal antibodies

You may be a good candidate for treatment with monoclonal antibodies if you meet certain qualifications. 

You must:

You have a high risk of becoming seriously ill if you’re 65 years of age or older or you have a medical condition such as:

You may be considered a high-risk patient if you’re pregnant or you take immunosuppressant medications. Your doctor can also determine you have a higher risk if you have other conditions that aren’t on this list.

Once your doctor prescribes monoclonal antibodies, the medications are infused intravenously at Align Infusion. Our highly qualified team gives you personalized care and attention while you get your treatment in our calming environment.

If you have questions about COVID-19 antibody infusions or need to schedule an appointment, call our office or book an appointment online.